subgroup
of
drug)
→
ReceivesAction
→
approved by the fda
Typicality: | 0.732 |
Saliency: | 0.749 |
prior to patent expiration | 4 | temporal |
for sale to the public | 3 | purpose |
generic drug → be approved by → the fda | 18 |
generic drug → be → approved | 16 |
generic drug → be approved by → fda | 7 |
generic drug → be approved for → sale | 3 |
negative | neutral | positive |
0.080 | 0.608 | 0.312 |
Raw frequency | 44 |
Normalized frequency | 0.749 |
Modifier score | 1.000 |
Perplexity | 36.084 |